Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04464785 · ClinicalTrials.gov registry record
CentriMag Failure-to-Wean Post Approval Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 32
- Enrollment target
NCT04464785: Completed study, sponsored by Abbott Medical Devices.
NCT04464785 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04464785 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The primary objective of this Post Approval Study is to report the proportion of patients surviving to 30 days post CentriMag support or to hospital discharge, whichever is longer. For subjects who do not recover and are bridged to a heart transplant or a long-term assist device, the primary endpoint is survival to induction of anesthesia for the surgery.
Primary Outcome
The proportion of subjects who survive to 30 days post CentriMag support or to hospital discharge (whichever is longer).
Interventions
- DEVICE CentriMag Circulatory Support System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-12-30 |
| Est. Completion | 2024-10-25 |
What the finished NCT04464785 record still lists
NCT04464785 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CentriMag Circulatory Support System is the first listed.
NCT04464785 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04464785 about?
NCT04464785 is a clinical study titled "CentriMag Failure-to-Wean Post Approval Study". The primary objective of this Post Approval Study is to report the proportion of patients surviving to 30 days post CentriMag support or to hospital discharge, whichever is longer. For subjects who do not recover and are bridged to a heart transplant or a long-term assist device, the primary endpoin...
What is the current status of trial NCT04464785?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2020-12-30. Estimated completion is 2024-10-25.
What interventions are being tested in trial NCT04464785?
The interventions under investigation include: CentriMag Circulatory Support System (DEVICE).
Who is sponsoring clinical trial NCT04464785?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI